Among these goals is certainly our desire to provide innovative technology to the Taiwan medical community, to broaden our current product offerings in the oncology segment, and lastly and most importantly, to support the government healthcare system initiatives to potentially decrease the death price and improve the standard of living for hepatic cancer patients. We further discover this as the first rung on the ladder in building a strong partnership with Delcath as their platform technology is definitely adapted to take care of new cancers and various other disease indications in the future.. Chi-Fu Trading to market and sell Delcath PHP Systems in Taiwan Delcath Systems, Inc., Ltd. The exclusive right to marketplace and sell the Delcath PHP Program in Taiwan for hepatic malignancies and infectious disease upon Taiwan Food and Drug Administration approval, and any other approved use, with a conditional option for Singapore.‘If established, we believe it could set a fresh standard for cardiac tension testing.’ Around 40 million cardiac tension tests in a variety of modalities are performed annually in the United States. In December of 2009 Cambridge Heart filed a patent application related to ischemia.. Blood pressure lowering associated with reduced risk for cognitive decline in individuals with T2DM Intensive blood circulation pressure and cholesterol decreasing was not connected with decreased risk for diabetes-related cognitive decline in old patients with long-standing up type 2 diabetes mellitus, relating to a scholarly research by Jeff D. Williamson, M.D., M.H.S., of the Wake Forest College of Medication, Winston-Salem, N.C., and colleagues.